Patent · US Active

Methods and compositions for treating pancreatitis

US10758551B2 · kind B2 · utility

0Cited by

0References

9Claims

0Family size

Assignee

BAYLOR RESEARCH INSTITUTE · US

Inventors

Mazhar Adnan Kanak · Dallas, US
Bashoo Naziruddin · Plano, US
Marlon F. Levy · Dallas, US

Key dates

Filing date	Mar 30, 2016
Grant date	Sep 1, 2020
Priority date	—
Expiry date	Mar 30, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P1/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

It was discovered that NF-κB signaling pathway plays a central role in pancreatitis, and inhibition of NF-κB signaling has the potential to reduce the incidence of pancreatitis and protect pancreatic tissues from inflammatory damage. Aspects of the disclosure relate to a method for inhibiting or treating pancreatitis in a subject in need thereof comprising administering a therapeutically effective amount of an NF-κB signaling pathway inhibitor to the subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.